Global Cord Blood Corporation
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Ting Zheng
- Full Time Employees
- 1,202
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Address
- Bank of China Tower Central Hong Kong
- IPO Date
- May 9, 2007
- CIK
- 0001467808
- Website
- globalcordbloodcorp.com
- Similar Companies
- Business
- Global Cord Blood Corporation (CORBF) operates as a biotechnology company focused on cord blood banking and stem cell services in China. The company collects, processes, and stores umbilical cord blood units containing hematopoietic stem cells for potential future medical use; it also provides matching and transplantation services through its network of cord blood banks and related facilities. Its core offerings include cord blood storage subscriptions for expectant parents, stem cell therapy development, and ancillary services such as cryopreservation and genetic testing, primarily targeting individual consumers and medical institutions in the healthcare sector. Founded in 2004 and headquartered in Hong Kong, Global Cord Blood Corporation manages operations predominantly in mainland China, including multiple cord blood banks in key provinces like Guangdong, Zhejiang, and Beijing, with no major subsidiaries or parent company relationships publicly noted in recent updates. The company serves the regenerative medicine and biobanking industries, catering to families seeking long-term stem cell preservation and hospitals requiring transplant resources. In the last 1-2 years, the company has pursued strategic expansions in stem cell research and therapy applications amid China's growing biotech sector, though specific details on recent partnerships, funding rounds, acquisitions, or product launches remain limited in public disclosures as of late 2025; ongoing operational enhancements focus on scaling storage capacity and regulatory compliance for broader market penetration.
Global Cord Blood Corporation Investors With Losses Are Urged By The Schall Law Firm To Start Communication Be Mindful Of The Deadline In This Case
The Schall Law Firm Encourages Global Cord Blood Corporation Investors With Losses To Initiate Communication Be Conscious Of The Time Limit In This Situation
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Global Cord Blood Corporation of Class Action Lawsuit and Upcoming Deadlines - CORBF
CO, CORBF DEADLINE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Global Cord Blood Corporation Investors to Secure Counsel Before Important June 24 Deadline in Securities Class Action – CO, CORBF
Investors Who Have Incurred Losses In Global Cord Blood Corporation Are Encouraged By The Schall Law Firm To Reach Out Please Be Mindful Of The Deadline In This Matter
Investors Who Have Sustained Losses In Global Cord Blood Corporation Are Urged By The Schall Law Firm To Make Contact Please Be Aware Of The Deadline In This Case
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Global Cord Blood Corporation of Class Action Lawsuit and Upcoming Deadlines – CORBF
CO, CORBF Deadline: CO, CORBF Investors Have the Opportunity to Lead Global Cord Blood Corporation Securities Fraud Lawsuit
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Global Cord Blood Corporation of Class Action Lawsuit and Upcoming Deadlines – CORBF
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Global Cord
Investors Who Have Incurred Losses In Global Cord Blood Corporation Are Encouraged By The Schall Law Firm To Reach Out Please Be Mindful Of The Deadline In This Matter
CORBF Investors Have Opportunity to Join Global Cord Blood Corporation Secruties Fraud Law Firm with the Schall Law Firm
Global Cord Blood Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CORBF
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Global Cord Blood Corporation Investors to Secure Counsel Before Important June 24 Deadline in Securities Class Action – CO, CORBF
CORBF Investors Have Opportunity to Lead Global Cord Blood Corporation Securities Fraud Lawsuit
The Schall Law Firm Encourages Investors Who Have Incurred Losses In Global Cord Blood Corporation To Reach Out Please Note The Deadline In This Matter
Investors With Losses In Global Cord Blood Corporation Are Encouraged By The Schall Law Firm To Make Contact Be Mindful Of The Matter Deadline
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Global Cord Blood Corporation (CORBF)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Global Cord Blood Corporation of Class Action Lawsuit and Upcoming Deadlines – CORBF
The Schall Law Firm Is Encouraging Investors Who Have Incurred Losses In Global Cord Blood Corporation To Establish Contact Please Be Mindful Of The Deadline In This Matter